FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/10/028692 [Registered on: 28/10/2020] Trial Registered Prospectively
Last Modified On: 19/10/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Azithromycin with full mouth cleaning in pyorrhoea patients 
Scientific Title of Study   Azithromycin as an Adjunct to One- Stage Full-Mouth Disinfection in Stage III Grade B Unstable generalised periodontitis: A Randomized Controlled Clinical Trial”  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chitrika Subhadarsanee  
Designation  Postgraduate Student  
Affiliation  Sharad pawar dental college 
Address  Department of periodontology and implantology, ROOM no-003 sharad pawar dental college,DMIMS,sawangi (Meghe) Sharad Pawar Dental College,sawangi(Meghe),wardha, MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  08763072403  
Fax    
Email  chitrikasubhadarsanee403@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pavan Bajaj 
Designation  Reader 
Affiliation  Sharad pawar dental college 
Address  Department of periodontology and implantology, ROOM no-003 sharad pawar dental college,DMIMS,sawangi (Meghe) Sharad Pawar Dental College,sawangi(Meghe),wardha,MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  08412045019  
Fax    
Email  pavbajaj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pavan Bajaj 
Designation  Reader 
Affiliation  Sharad pawar dental college 
Address  Department of periodontology and implantology, ROOM no-003 sharad pawar dental college,DMIMS,sawangi (Meghe) Sharad Pawar Dental College,sawangi(Meghe),wardha, MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  08412045019  
Fax    
Email  pavbajaj@gmail.com  
 
Source of Monetary or Material Support  
NA 
 
Primary Sponsor  
Name  Sharad Pawar Dental College Hospital 
Address  Sawwangi(Meghe),Wardha  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr chitrika Subhadarsanee   Sharad Pawar Dental College & Hospital  Department of Periodontics,Room Number-003,sawangi
Wardha
MAHARASHTRA 
08763072403

chitrikasubhadarsanee403@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K052||Aggressive periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Full mouth disinfection (chlorhexidine gel and mouthwash)  15 subjects will be treated with full mouth disinfection (chlorhexidine gel and mouthwash) 
Intervention  Full mouth disinfection (chlorhexidine gel and mouthwash) with azithromycin   15 subjects will be treated with full mouth disinfection (chlorhexidine gel and mouthwash) with azithromycin 500mg once daily for 7 days 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1.Generalized interproximal attachment loss involving at least three teeth apart from molars and first incisors.
2.Amount of microbial deposits inconsistent with the severity of periodontal tissue destruction.
3.Patients with a minimum number of 20 teeth.
4.Patients with clinical attachment loss and probing depths (PDs) ≥ 4 mm at 2 sites of a minimum of 12 teeth
5.The patients included in the study should be systemically healthy.
6.Patients with no history of periodontal therapy in the preceding 6 months or under any antibiotic therapy.
7.Patients motivated to have the therapy and willing to complete the follow-up.
 
 
ExclusionCriteria 
Details  1.Patients with a known or suspected allergy
2.Patients who have undergone periodontal therapy in the last 6 months.
3.Patients with any systemic disorder affecting periodontal health.
4.Patients with infectious conditions other than periodontitis.
5.Chronic alcoholics
6.Patients consuming tobacco in any form and smokers.
7.Immuno-compromised and systemically-unhealthy patients.
8.Pregnant or lactating females.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in Probing Pocket depth (PPD)  3 and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in Bleeding on Probing (BOP), Gain in Clinical attachment level (CAL)  Reduction in Bleeding on Probing (BOP), Gain in Clinical attachment level (CAL) at 3 and 6 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   02/11/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The aim of this randomized clinical trial was to evaluate whether the adjunctive use of systemic azithromycin improves clinical outcomes in the treatment of Stage III Grade B Unstable generalised periodontitis.

Sample size calculation-

Sample size was calculated using the data of the previous studies Gazal Jain et al 2018  by using OpenEpi, version 3,open source calculator—SSMean(calculation shown at the end).The result of the calculation is 28, so a around figure of 30 sample will be undertaken for the study.      

Inclusion criteria-          

1.Generalized interproximal attachment loss involving at least three teeth apart from molars and first incisors.

2.Amount of microbial deposits inconsistent with the severity of periodontal tissue destruction.

3.Patients with a minimum number of 20 teeth.

4.Patients with clinical attachment loss and probing depths (PDs)  ≥ 4 mm at 2 sites of a minimum of 12 teeth

5.The patients included in the study should be systemically healthy.

6.Patients with no history of periodontal therapy in the preceding 6 months or under any antibiotic therapy.

7.Patients motivated to have the therapy and willing to complete the follow-up.       

Exclusion criteria-                                                

1.Patients with a known or suspected allergy 

2.Patients who have undergone periodontal therapy in the last 6 months.

3.Patients with any systemic disorder affecting periodontal health.

4.Patients with infectious conditions other than periodontitis.

5.Chronic alcoholics

6.Patients consuming tobacco in any form and smokers.

7.Immuno-compromised and systemically-unhealthy patients.

8.Pregnant or lactating females.

Material and method- There will be two groups in this study i. Intervantion group ii. Comparator agent. In intervantion group, 15 subjects will be treated with full mouth disinfection (chlorhexidine gel and mouthwash). In comparator agent, 15 subjects will be treated with full mouth disinfection (chlorhexidine gel and mouthwash) with systemic azithromycin 500mg once daily for 7 days.


 
Close